[The effectiveness of cardiac contractility modulation in patients with chronic heart failure and atrial fibrillation: results of the 12-month follow-up].
A A SafiullinaT M UskachO V Sapel'nikovI R GrishinD I CherkashinV A AmanatovaR S AkchurinSergey TereshchenkoPublished in: Terapevticheskii arkhiv (2022)
The use of CCM in patients with CHF and atrial fibrillation is an effective and safe method of therapy that leads to the development of reverse remodeling of the myocardium, improves the clinical status of patients and reduces the frequency of readmission due to decompensation of CHF.
Keyphrases
- atrial fibrillation
- ejection fraction
- end stage renal disease
- left atrial
- oral anticoagulants
- newly diagnosed
- heart failure
- chronic kidney disease
- randomized controlled trial
- catheter ablation
- systematic review
- peritoneal dialysis
- direct oral anticoagulants
- prognostic factors
- percutaneous coronary intervention
- left ventricular
- stem cells
- coronary artery disease
- patient reported outcomes
- bone marrow
- mitral valve
- patient reported
- venous thromboembolism
- smooth muscle